Bio-Techne Corp. (TECH) Stock Price Chart, Business Overview & Key Insights, Historical Stock Splits, Cash Flow Statement, Income Statement, Balance Sheet, Historical Dividends, Recent News, & Related Companies.

$

9

8

7

6

5

4

3

2

1

0

0

9

8

7

6

5

4

3

2

1

0

0

.

9

8

7

6

5

4

3

2

1

0

0

-$1.41 (-2.40%)Past DayToday's Volume:

9

8

7

6

5

4

3

2

1

0

0

9

8

7

6

5

4

3

2

1

0

0

9

8

7

6

5

4

3

2

1

0

0

,

9

8

7

6

5

4

3

2

1

0

0

9

8

7

6

5

4

3

2

1

0

0

9

8

7

6

5

4

3

2

1

0

0

,

9

8

7

6

5

4

3

2

1

0

0

Toggle RSI

About

Bio-Techne Corp. (TECH) Business Model and Operations Summary

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Key Insights

Bio-Techne Corp. (TECH) Core Market Data and Business Metrics

Latest Closing Price
$57.35
Market Cap
$9.05 Billion
Price-Earnings Ratio
60.37
Total Outstanding Shares
158.09 Million Shares
Total Employees
3,100
Dividend
$0.08 Per Share Quarterly
IPO Date
December 9, 1992
SIC Description
Biological Products, (no Disgnostic Substances)
Primary Exchange
NASDAQ
Headquarters
614 Mckinley Pl N E, Minneapolis, MN, 55413

Historical Stock Splits

If you bought 1 share of TECH before November 30, 2022, you'd have 4 shares today.

Execution Date	Split Amount
November 30, 2022	4-for-1

Cash Flow Statement

October 1, 2023 to September 30, 2024

Metric	Value
Net Cash Flow	$27.40 Million
Net Cash Flow From Operating Activities, Continuing	$303.49 Million
Net Cash Flow From Financing Activities	$-205.48 Million
Net Cash Flow From Investing Activities	$-70.60 Million
Net Cash Flow From Operating Activities	$303.49 Million
Net Cash Flow, Continuing	$27.40 Million

Income Statement

October 1, 2023 to September 30, 2024

Metric	Value
Preferred Stock Dividends And Other Adjustments	$20,000
Basic Average Shares	$473.43 Million
Other Operating Expenses	$96.53 Million
Benefits Costs and Expenses	$995.28 Million
Costs And Expenses	$995.28 Million
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	$40,000

Comprehensive Income

October 1, 2023 to September 30, 2024

Metric	Value
Comprehensive Income/Loss Attributable To Noncontrolling Interest	$0
Comprehensive Income/Loss	$154.29 Million
Other Comprehensive Income/Loss	$17.93 Million
Comprehensive Income/Loss Attributable To Parent	$168.64 Million

Balance Sheet

October 1, 2023 to September 30, 2024

Metric	Value
Fixed Assets	$253.94 Million
Inventory	$185.04 Million
Current Assets	$648.57 Million
Accounts Payable	$31.56 Million
Other Current Assets	$463.53 Million
Current Liabilities	$142.13 Million

Historical Dividends

Current dividend: $0.08 Per Share Quarterly

Announcement Date	Payment Date	Record Date	Amount	Frequency
Feb 5, 2025	Feb 28, 2025	Feb 17, 2025	$0.08	Quarterly
Oct 30, 2024	Nov 22, 2024	Nov 11, 2024	$0.08	Quarterly
Aug 7, 2024	Aug 30, 2024	Aug 19, 2024	$0.08	Quarterly
May 1, 2024	May 24, 2024	May 13, 2024	$0.08	Quarterly
Feb 1, 2024	Feb 26, 2024	Feb 12, 2024	$0.08	Quarterly
Oct 31, 2023	Nov 24, 2023	Nov 10, 2023	$0.08	Quarterly

Recent Headlines From The Web

Latest news, press releases, and media coverage about TECH from trusted financial sources

Related Companies

Publicly traded companies similar to Bio-Techne Corp. (TECH)